Atara Biotherapeutics Inc reports results for the quarter ended in December - Earnings Summary

Atara Biotherapeutics

28/03/2024 13:40

* Atara Biotherapeutics Inc  ATRA.OQ  reported a quarterly
adjusted loss of 56 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -72 cents.  The mean expectation of
six analysts for the quarter was for a loss of 48 cents per
share. Wall Street expected results to range from -62 cents
to -31 cents per share.
    * Revenue rose 1,824% to $4.25 million from a year ago;
analysts
expected $11.55 million. 
    * Atara Biotherapeutics Inc's reported EPS for the quarter
was a
loss of 56 cents​.
    * The company reported a quarterly loss of $60.45 million.
    * Atara Biotherapeutics Inc shares had risen by 36.5% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 10.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Atara
Biotherapeutics Inc is $2.90 
This summary was machine generated from LSEG data March 28 at
01:40 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.48          -0.56          Missed
 Sep. 30 2023      -0.66          -0.66          Met
 Jun. 30 2023      -0.67          -0.68          Missed
 Mar. 31 2023      -0.39          -0.72          Missed